Agios Pharmaceuticals, Inc. · NASDAQ:AGIO
Scadden David exercised options for 2,816 Agios Pharmaceuticals, Inc. shares (Form 4)
Traded Jun 18, 2026 · Filed Jun 23, 2026
On Jun 18, 2026, Scadden David (Director) exercised options for 2,816 Agios Pharmaceuticals, Inc. shares, leaving 20,419 shares. Filed Jun 23, 2026 (Form 4).
- Options exercised
- 2,816 shares
- Holding after
- 20,419 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 18, 2026 | Common stock | Option exercise | 2,816 | 20,419 | Direct |
Source
Related
- Agios Pharmaceuticals, Inc.
- Scadden David
- Agios Pharmaceuticals, Inc. shareholders
- Form 4 · Gheuens Sarah · Aug 6, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 3, 2026
- Form 4 · Backstrom Jay T. · Jul 10, 2026
- Form 4 · Gheuens Sarah · Jul 2, 2026
- Schedule 13G · D. E. Shaw & Co., L.P. · Jul 2, 2026